STAT+: Pharmalittle: We’re reading about pharma lobbying, a disappointing Novo clinical trial, and much more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned. Settling in may be a little more challenging for those of you who, lik...

🔗 Read more: https://www.statnews.com/pharmalot/2026/02/23/pharma-lobbying-novo-obesity-merck-gilead-tariffs/?utm_campaign=rss

#News #Medicine #Business #Biology #Health #Software #Science